These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. Pharmacological therapy for the prevention and management of cardiomyopathy in Duchenne muscular dystrophy: A systematic review. El-Aloul B; Altamirano-Diaz L; Zapata-Aldana E; Rodrigues R; Malvankar-Mehta MS; Nguyen CT; Campbell C Neuromuscul Disord; 2017 Jan; 27(1):4-14. PubMed ID: 27815032 [TBL] [Abstract][Full Text] [Related]
17. [Pluripotent stem cells lacking dystrophin transformed into cardiomyocytes]. Mornet D Med Sci (Paris); 2020 Dec; 36 Hors série n° 2():55. PubMed ID: 33427638 [No Abstract] [Full Text] [Related]
18. Cardiomyopathy in a dish: using human inducible pluripotent stem cells to model inherited cardiomyopathies. Kamdar F; Klaassen Kamdar A; Koyano-Nakagawa N; Garry MG; Garry DJ J Card Fail; 2015 Sep; 21(9):761-70. PubMed ID: 25934595 [TBL] [Abstract][Full Text] [Related]
19. New approaches in the therapy of cardiomyopathy in muscular dystrophy. McNally EM Annu Rev Med; 2007; 58():75-88. PubMed ID: 17217326 [TBL] [Abstract][Full Text] [Related]
20. Long-term culture of patient-derived cardiac organoids recapitulated Duchenne muscular dystrophy cardiomyopathy and disease progression. Marini V; Marino F; Aliberti F; Giarratana N; Pozzo E; Duelen R; Cortés Calabuig Á; La Rovere R; Vervliet T; Torella D; Bultynck G; Sampaolesi M; Chai YC Front Cell Dev Biol; 2022; 10():878311. PubMed ID: 36035984 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]